announces

EVEREADY ANNOUNCES HARRY KANE AS GLOBAL BRAND AMBASSADOR

Partnership with international football star and family man is part of broader international marketing effort to expand brand presence around…

7 months ago

1664 Announces Robert Pattinson as New Global Brand Ambassador

The French beer brand unveils a bold new partnership with global icon Robert Pattinson, a creative campaign celebrating a multi-faceted…

7 months ago

Kia Announces September 2025 Global Sales Results

September 2025 global sales of 268,238 units, up 7.3% Y/ySales in Korea climbed to 49,001 units, up 28.5% Y/yOutside of…

7 months ago

ArriTech Announces Its Next-Generation QGen Online Platform for No-Code, AI-Driven KYC, KYB, AML & Biometrics

FLORIANA, Malta, Sept. 30, 2025 /PRNewswire/ -- ArriTech today announced the next generation of QGen Online, its software platform that…

7 months ago

GIGABYTE Announces Availability of 27″ QHD 280Hz WOLED Gaming Monitor MO27Q28G with 4-Sided Borderless Design

TAIPEI, Sept. 30, 2025 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announces the availability of the GIGABYTE MO27Q28G, a…

7 months ago

Databricks Announces Data Intelligence for Cybersecurity

The only unified platform for AI agent systems, enabling more accurate, real-time response against AI-driven threats SAN FRANCISCO, Sept. 30,…

7 months ago

The SANDChain Foundation announces SANDchain to power creator economy transparently and equitably

SINGAPORE, Sept. 30, 2025 /PRNewswire/ -- The SANDChain Foundation today announced SANDchain, a creator-first blockchain network to build upon The…

7 months ago

BitMine Immersion (BMNR) Announces ETH Holdings Exceeding 2.65 Million Tokens and Total Crypto and Cash Holdings of $11.6 Billion

BitMine now owns greater than 2% of the ETH token supply as it moves towards the 'Alchemy of 5%' BitMine…

7 months ago

Artelo Biosciences Announces Proposed Underwritten Public Offering

September 29, 2025 19:15 ET  | Source: Artelo Biosciences SOLANA BEACH, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences,…

8 months ago

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Nave or Resistant R/M-HNSCC

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…

8 months ago